{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:37:04Z","timestamp":1783111024522,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["(077092\/B\/05\/Z)"],"award-info":[{"award-number":["(077092\/B\/05\/Z)"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Burkitt\u2019s lymphoma (BL) is a type of non-Hodgkin lymphoma that may account for more than 40% of childhood malignancies in tropical Africa. The endemic version is common in equatorial Africa, where a BL belt has been mapped. The role of\n                      <jats:italic>P. falciparum malaria<\/jats:italic>\n                      infection in BL has been postulated but not substantiated. The decrease in\n                      <jats:italic>P. falciparum malaria<\/jats:italic>\n                      infection offers an opportunity to examine this association.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we utilized data collected over three decades (1990\u20132020) and examined the trends in annual admission incidence rates of Burkitt\u2019s lymphoma among pediatric admissions (0\u201314 years) in relation to the reduction in malaria admissions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>\n                      Ninety-five patients with Burkitt\u2019s lymphoma were identified, of whom 72 (75.8%) were male. During the first epoch (1990\u20131999) and second decade, 29 cases and 62 cases were diagnosed, resulting in 10-year cumulative incidence rates of 93.1 cases and 130.3 cases per 100,000, respectively. In the third decade, 2010\u20132020, there were only 4 cases (cumulative incidence of 10.2 cases per 100,000). With one-way ANOVA, the F statistic for within- and between-group comparisons was significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), indicating that the decline across the three epochs was statistically significant. Similarly, the median parasite density decreased from 13,966 (Q1:2090, Q3:126,000) in the first epoch to 7,224 (Q1:1566, Q3:109,200) in the third epoch (Kruskal\u2012Wallis chi-square test, 12.3;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0021). One-way ANOVA for within- and between-group comparisons was equally significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The correlation coefficient between endemic BL and\n                      <jats:italic>P. falciparum malaria<\/jats:italic>\n                      infection was 0.53, indicating a strong positive correlation (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0024), implying that as\n                      <jats:italic>P. falciparum malaria<\/jats:italic>\n                      infection decreased, the endemic BL incidence rate decreased.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>There has been a significant reduction in the annual incidence rates of Burkitt\u2019s lymphoma in the coastal region of Kenya. It is plausible that this decrease can be explained by an equally sustained and significant decline in the number of falciparum malaria infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-15450-9","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:18:30Z","timestamp":1766053110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A \u201cFamiliar Foe Revisited\u201d: examining the relationship between endemic Burkitt\u2019s lymphoma and changing malaria admissions in the coastal region of Kenya"],"prefix":"10.1186","volume":"25","author":[{"given":"Michael K.","family":"Mwaniki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shebe","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyambura","family":"Kariuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalton C.","family":"Wamalwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Mutisya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"15450_CR1","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A,Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence andMortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. https:\/\/doi.org\/10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"key":"15450_CR2","doi-asserted-by":"publisher","unstructured":"Joko-Fru WY, Parkin DM, Borok M, Chokunonga E, Korir A, Nambooze S, et al. Survival fromchildhood cancers in Eastern Africa: A population-based registry study. Int J Cancer. 2018;143(10):2409-415. https:\/\/doi.org\/10.1002\/ijc.31723.\u00a0","DOI":"10.1002\/ijc.31723"},{"key":"15450_CR3","doi-asserted-by":"publisher","unstructured":"Johnston WT, Erdmann F, Newton R, Steliarova-Foucher E, Sch\u00fcz J, Roman E. Childhood cancer: Estimating regional and global incidence. CancerEpidemiol. 2021;71(Pt B):101662. https:\/\/doi.org\/10.1016\/j.canep.2019.101662.","DOI":"10.1016\/j.canep.2019.101662"},{"key":"15450_CR4","doi-asserted-by":"publisher","unstructured":"Bhakta N et al. Childhood cancer burden: a review of global estimates. Lancet Oncol. 2019;20 at.\u00a0https:\/\/doi.org\/10.1016\/S1470-2045(18)30761-7.","DOI":"10.1016\/S1470-2045(18)30761-7"},{"key":"15450_CR5","doi-asserted-by":"publisher","unstructured":"Parkin DM, Youlden DR, Chitsike I, Chokunonga E, Couitch\u00e9\u00e9r\u00e9\u00e9 L, Gnahatin F, et al. Stage at diagnosis and survival by stage for the leading childhoodcancers in three populations of sub-Saharan Africa. Int J Cancer. 2021;148(11):2685\u2013691. https:\/\/doi.org\/10.1002\/ijc.33468.","DOI":"10.1002\/ijc.33468"},{"key":"15450_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1053\/j.sempedsurg.2012.01.006","volume":"21","author":"LGP Hadley","year":"2012","unstructured":"Hadley LGP, Rouma BS, Saad-Eldin Y. Challenge of pediatric oncology in Africa. Semin Pediatr Surg. 2012;21:136\u201341.","journal-title":"Semin Pediatr Surg"},{"key":"15450_CR7","unstructured":"America COS. Lymphoma - Non-Hodgkin: Subtypes https:\/\/www.cancer.net\/cancer-types\/lymphoma-nonhodgkin\/subtypes."},{"key":"15450_CR8","doi-asserted-by":"publisher","unstructured":"H\u00e4\u00e4mmerl L, ColombetM, Rochford R, Ogwang DM, Parkin DM. The burden of Burkitt lymphoma in Africa. Infect AgentCancer. 2019;14:17. https:\/\/doi.org\/10.1186\/s13027-019-0236-7.","DOI":"10.1186\/s13027-019-0236-7"},{"key":"15450_CR9","doi-asserted-by":"publisher","unstructured":"Mwanda OW. Clinical characteristics of Burkitt's lymphoma seen inKenyan patients. East Afr Med J. 2004;(8 Suppl):S78\u201389. https:\/\/doi.org\/10.4314\/eamj.v81i8.9211.","DOI":"10.4314\/eamj.v81i8.9211"},{"key":"15450_CR10","doi-asserted-by":"publisher","unstructured":"Mawson AR, Majumdar S. Malaria, Epstein-Barr virus infectionand the pathogenesis of Burkitt's lymphoma. Int J Cancer. 2017;141(9):1849\u201355. https:\/\/doi.org\/10.1002\/ijc.30885.","DOI":"10.1002\/ijc.30885"},{"key":"15450_CR11","doi-asserted-by":"publisher","unstructured":"Chene A et al. Endemic Burkitt\u2019s lymphoma as a polymicrobial disease. New insights on the interaction between Plasmodium falciparum and Epstein\u2013Barr virus. Semin Cancer Biol. 2009;19 at.\u00a0https:\/\/doi.org\/10.1016\/j.semcancer.2009.10.002.","DOI":"10.1016\/j.semcancer.2009.10.002"},{"key":"15450_CR12","doi-asserted-by":"publisher","unstructured":"Moormann AM, Bailey JA. Malaria \u2014 how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis. Curr Opin Virol. 2016;20 at.\u00a0https:\/\/doi.org\/10.1016\/j.coviro.2016.09.006.","DOI":"10.1016\/j.coviro.2016.09.006"},{"key":"15450_CR13","doi-asserted-by":"publisher","unstructured":"Rainey JJ, Mwanda WO,Wairiumu P, Moormann AM, Wilson ML, Rochford R. Spatial distribution of Burkitt's lymphomain Kenya and association with malaria risk. Trop Med Int Health. 2007;12(8):93643. https:\/\/doi.org\/10.1111\/j.1365-3156.2007.01875.x.","DOI":"10.1111\/j.1365-3156.2007.01875.x"},{"key":"15450_CR14","doi-asserted-by":"publisher","unstructured":"Njuguna P, Maitland K, Nyaguara A, MwangaD, Mogeni P, Mturi N, et al. Observational study: 27\u00a0years of severe malaria surveillance in Kilifi,Kenya. BMC Med. 2019;17(1):124. https:\/\/doi.org\/10.1186\/s12916-019-1359-9.","DOI":"10.1186\/s12916-019-1359-9"},{"key":"15450_CR15","doi-asserted-by":"publisher","unstructured":"O\u2019Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis. 2010;10 at.\u00a0https:\/\/doi.org\/10.1016\/S1473-3099(10)70096-7.","DOI":"10.1016\/S1473-3099(10)70096-7"},{"key":"15450_CR16","unstructured":"PocketBook of Hospital Care for Children, 2nd edition. Guidelines for the Management of CommonChildhood Illnesses Geneva: World Health Organization; 2013. ISBN-13: 978-92-4-154837-3"},{"key":"15450_CR17","doi-asserted-by":"publisher","unstructured":"Basaga\u00f1\u00f1a X, Xiaomei Liao, Spiegelman D. Power and sample size calculations forlongitudinal studies estimating a main effect of a time-varying exposure. Stat Methods Med Res. 2011;20(5):47110.1177\/096228021037156310.1177\/096228021037156387. https:\/\/doi.org\/10.1177\/0962280210371563.","DOI":"10.1177\/0962280210371563"},{"key":"15450_CR18","doi-asserted-by":"publisher","unstructured":"Mogeni P, Williams TN, Fegan G, Nyundo C, Bauni E, MwaiK, et al. Age, Spatial, and TemporalVariations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year LongitudinalObservational Study. PLoS Med. 2016;13(6):e1002047. https:\/\/doi.org\/10.1371\/journal.pmed.1002047.","DOI":"10.1371\/journal.pmed.1002047"},{"key":"15450_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-019-1184-4","volume":"8","author":"SR Ndlovu","year":"2019","unstructured":"Ndlovu SR, Kuupiel D, Ginindza TG. Mapping evidence on the distribution of pediatric cancers in sub-Saharan africa: A scoping review protocol. Syst Rev. 2019;8:1\u20135.","journal-title":"Syst Rev"},{"key":"15450_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/pbc.20917","volume":"48","author":"RL Sinfield","year":"2007","unstructured":"Sinfield RL, et al. Spectrum and presentation of pediatric malignancies in the HIV era: experience from Blantyre, Malawi, 1998\u20132003. Pediatr Blood Cancer. 2007;48:515\u201320.","journal-title":"Pediatr Blood Cancer"},{"key":"15450_CR21","doi-asserted-by":"publisher","unstructured":"Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM. Incidence and geographic distribution ofendemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer. 2008;123(11):2658\u201363. https:\/\/doi.org\/10.1002\/ijc.23800.","DOI":"10.1002\/ijc.23800"},{"key":"15450_CR22","doi-asserted-by":"publisher","unstructured":"Noy A. Burkitt Lymphoma - Subtypes, Pathogenesis, and Treatment Strategies. ClinLymphoma Myeloma Leuk. 2020;20 Suppl 1:S37-38. https:\/\/doi.org\/10.1016\/S2152-2650(20)30455-9.","DOI":"10.1016\/S2152-2650(20)30455-9"},{"key":"15450_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-4913-3","volume":"20","author":"PI Mayengue","year":"2020","unstructured":"Mayengue PI, et al. Variation of prevalence of malaria, parasite density and the multiplicity of plasmodium falciparum infection throughout the year at three different health centers in Brazzaville, Republic of congo. BMC Infect Dis. 2020;20:1\u201310.","journal-title":"BMC Infect Dis"},{"key":"15450_CR24","doi-asserted-by":"publisher","unstructured":"Peprah S, Ogwang MD, Kerchan P, Reynolds SJ, Tenge CN,Were PA, et al. Risk factors for Burkitt lymphoma in East African children and minors: A case-control study in malaria-endemic regions in Uganda, Tanzania and Kenya. Int J Cancer. 2020 Feb 15;146(4):953-69. https:\/\/doi.org\/10.1002\/ijc.32390.","DOI":"10.1002\/ijc.32390"},{"key":"15450_CR25","doi-asserted-by":"publisher","unstructured":"Kamulegeya A, Muwazi L. Trends in Burkitt's lymphoma: a three-decade retrospective study from Uganda. Oral Surgery. 2010; doi:10.1111\/J.1752-248X.2010.01095.X 17. Citation 32 Boyle P, Ngoma T, Sullivan R, Brawley O. Cancer in Africa: the way forward. Ecancermedicalscience. 2019;13:953. https:\/\/doi.org\/10.3332\/ecancer.2019.953.","DOI":"10.3332\/ecancer.2019.953"},{"key":"15450_CR26","doi-asserted-by":"publisher","first-page":"101965","DOI":"10.1016\/j.canep.2021.101965","volume":"73","author":"GYC Chun","year":"2021","unstructured":"Chun GYC, Sample J, Hubbard AK, Spector LG, Williams L. A. Trends in pediatric lymphoma incidence by global region, age and sex from 1988\u20132012. Cancer Epidemiol. 2021;73:101965.","journal-title":"Cancer Epidemiol"},{"key":"15450_CR27","doi-asserted-by":"crossref","unstructured":"Aka P et al. Incidence and trends in Burkitt lymphoma in Northern Tanzania from 2000 to 2009. Pediatr Blood Cancer. 2012;59.","DOI":"10.1002\/pbc.24194"},{"key":"15450_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/cncr.33280","volume":"127","author":"J Githang\u2019a","year":"2021","unstructured":"Githang\u2019a J, et al. The cost-effectiveness of treating childhood cancer in 4 centers across sub-Saharan Africa. Cancer. 2021;127:787\u201393.","journal-title":"Cancer"},{"key":"15450_CR29","doi-asserted-by":"publisher","unstructured":"Ozuah NW, Lubega J, Allen CE, El-Mallawany NK. Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa. Blood Adv. 2020;4 at.\u00a0https:\/\/doi.org\/10.1182\/bloodadvances.2020002178.","DOI":"10.1182\/bloodadvances.2020002178"},{"key":"15450_CR30","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/cncr.32006","volume":"125","author":"AE Denburg","year":"2019","unstructured":"Denburg AE, et al. The cost effectiveness of treating Burkitt lymphoma in Uganda. Cancer. 2019;125:1918\u201328.","journal-title":"Cancer"},{"key":"15450_CR31","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.jval.2021.01.013","volume":"24","author":"L Conteh","year":"2021","unstructured":"Conteh L, et al. Costs and Cost-Effectiveness of malaria control interventions: A systematic literature review. Value Health. 2021;24:1213\u201322.","journal-title":"Value Health"},{"key":"15450_CR32","doi-asserted-by":"publisher","unstructured":"Boyle P, Ngoma T, Sullivan R, Brawley O.Cancer in Africa: the way forward. Ecancermedicalscience. 2019;13:953. https:\/\/doi.org\/10.3332\/ecancer.2019.953.\u00a0","DOI":"10.3332\/ecancer.2019.953"},{"key":"15450_CR33","doi-asserted-by":"crossref","unstructured":"Renner LA, McGill D. Exploring factors influencing health-seeking decisions and retention in childhoodcancer treatment programmes: perspectives of parents in Ghana. Ghana Med J. 2016;50(3):149\u201356.","DOI":"10.4314\/gmj.v50i3.6"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15450-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15450-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15450-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:21:59Z","timestamp":1781623319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15450-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15450"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15450-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7539041\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prospective surveillance (both inpatient and outpatient) focused on describing common childhood illness was instituted at the Kilifi site by Kenya Medical Research Institute (KEMRI) Center for Geographic Medicine Research Coast (CGMRC) from 1989. All Guardians are requested for consent to use the data of admitted children prospectively at the point of admission. This study utilized secondary anonymized data from the site and further individual consent to analyze the data was deemed not necessary. Importantly, all studies conducted via KEMRI adhere to internationally accepted norms including the Declaration of Helsinki. Given the retrospective nature of the study, waiver for specific consent to use the data was sought and granted by the ethical approval and review committee. The study was approved by Kenyatta National Hospital-University of Nairobi Ethical Review Committee (KNH-UON ERC), approval number\n                      P298\/04\/2022\n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1907"}}